Status:
NOT_YET_RECRUITING
Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Cohort of Adult Obese Patients and Longitudinal Follow-up
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Obesity and Overweight
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Context: Obesity, defined as excessive body fat, can lead to disability and loss of autonomy. If there is concomitant quantitative and qualitative muscle loss, sarcopenic obesity (SO) is suspected in ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age: 18-70
- Sex: men and women
- Clinical nutrition patient receiving a metabolic assessment to optimise clinical and paraclinical management
- Patient meeting obesity criteria defined by BMI \> 30 kg/m².
- Patient of legal age who has given free, informed and signed consent
- Patient covered by social security
- Non-inclusion criteria :
- Patients with cancer or severe chronic disease (renal failure, respiratory failure, liver failure)
- Patients with neuromuscular disease
- Patient with total walking disability
- Patients who are minors
- Patient refusing to take part in the study
- Pregnant or breast-feeding women
- Under guardianship, curatorship, deprived of liberty or under court protection
- Patient who has taken part in the OBESAR study
Exclusion
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2039
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06880432
Start Date
March 1 2025
End Date
December 1 2039
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France